
Calico Pharmaceuticals Private Limited
About Calico Pharmaceuticals Private Limited
Data last updated:
Calico Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 08 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2019PTC327720. Its GSTIN is 27AAICC2647L1ZC (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors Rajendra Gangaram Chavan and Rajashree Rajendra Chavan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.59 Lakh. For the same year it recorded a net loss of ₹16,300 (net margin -0.2%) and EBITDA of -₹2,300 (EBITDA margin 0%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years.
Company details
Contact details
Calico Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Calico Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Calico Pharmaceuticals Private Limited
FY 2025 filings availableCalico Pharmaceuticals Private Limited reported revenue of ₹80.59 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over three years. EBITDA rose 97% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2,300 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16,300 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0% | ||||
| Net Profit Margin | -0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Calico Pharmaceuticals Private Limited, buy the company report.
Board of directors of Calico Pharmaceuticals Private Limited
Calico Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Gangaram Chavan | Director | 08 Jul 2019 | 7 Years 4 Months | Current |
| Rajashree Rajendra Chavan | Director | 08 Jul 2019 | 7 Years 4 Months | Current |
Peer comparison
Calico Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Luxuriate Pharmaceuticals Private Limited | ₹80.95 Lakh (FY 2015) | Asansol, West Bengal, India | ||||
| Aileron Pharmaceuticals Private Limited | ₹80.87 Lakh (FY 2025) | 15.0% | Jaipur, Rajasthan, India | |||
| Rennova Pharmaceuticals Private Limited | ₹80.86 Lakh (FY 2025) | -40.0% | Kolhapur, Maharashtra, India | |||
| SV Well and Care Pharmaceuticals Private Limited | ₹80.76 Lakh (FY 2025) | -18.0% | Dehradun, Uttarakhand, India | |||
| Belgrand Pharmaceuticals Private Limited | ₹80.59 Lakh (FY 2024) | 21.0% | Hyderabad, Telangana, India | |||
| Calico Pharmaceuticals Private Limitedthis company | ₹80.59 Lakh (FY 2025) | -₹16,300 | -0.2% | Mumbai, Maharashtra, India | ||
| Zeneast Pharmaceuticals Private Limited | ₹80.48 Lakh (FY 2024) | 14.0% | Bhubaneswar, Odisha, India | |||
| Cypress Pharmaceuticals Private Limited | ₹80.44 Lakh (FY 2020) | -84.0% | Mumbai, Maharashtra, India | |||
| Medyur Pharmaceuticals Limited | ₹80.41 Lakh (FY 2025) | 68.0% | New Delhi, Delhi, India | |||
| Altoven Pharmaceuticals Private Limited | ₹80.39 Lakh (FY 2024) | 494.0% | Chennai, Tamil Nadu, India | |||
| Loyol Pharmaceuticals Private Limited | ₹80.32 Lakh (FY 2021) | Balasore, Odisha, India |
To see the full peer comparison of Calico Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Calico Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Calico Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Calico Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC2647L1ZC | Maharashtra | Active | 03 Dec 2020 |
To see the full GST registrations and return filing status of Calico Pharmaceuticals Private Limited, buy the company report.
Recent activity
Calico Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rajashree Rajendra Chavan was appointed as Director on 08 Jul 2019.
Frequently asked questions
Calico Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 08 July 2019 (7+ years old) and is registered under CIN U24304MH2019PTC327720.
Calico Pharmaceuticals has 2 current directors:
- Rajendra Gangaram Chavan - Director
- Rajashree Rajendra Chavan - Director
The latest financial statements of Calico Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Calico Pharmaceuticals is 27AAICC2647L1ZC, registered in Maharashtra.
The CIN (Corporate Identification Number) of Calico Pharmaceuticals is U24304MH2019PTC327720. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Calico Pharmaceuticals was incorporated on 08 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Calico Pharmaceuticals by revenue are Luxuriate Pharmaceuticals Private Limited, Aileron Pharmaceuticals Private Limited, Rennova Pharmaceuticals Private Limited, SV Well and Care Pharmaceuticals Private Limited, Belgrand Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rajashree Rajendra Chavan was appointed as Director on 08 Jul 2019. Rajendra Gangaram Chavan was appointed as Director on 08 Jul 2019.
The registered office of Calico Pharmaceuticals is at 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.
Calico Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Calico Pharmaceuticals can be reached at its registered office: 04 Panchakroshi Industrial Estate Sv Road Dahisar East Sambhaji Nagar, Mumbai, Maharashtra, India – 400068.

